What antibiotics are used to treat skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics for Skin Infections

For mild skin infections, first-line antibiotics include amoxicillin-clavulanic acid, cloxacillin, or cefalexin, while severe infections require combination therapy such as clindamycin plus piperacillin-tazobactam or ceftriaxone plus metronidazole, with vancomycin added for suspected MRSA. 1

Classification and First-Line Treatment

Mild to Moderate Skin Infections

  • First-choice antibiotics (per WHO guidelines):

    • Amoxicillin-clavulanic acid
    • Cloxacillin (or other anti-staphylococcal penicillins)
    • Cefalexin 1
  • For mild purulent infections (e.g., small abscesses):

    • Incision and drainage is primary treatment
    • Oral antibiotics if systemic symptoms present:
      • TMP-SMX (trimethoprim-sulfamethoxazole)
      • Doxycycline
      • Clindamycin 1
  • For mild non-purulent infections (e.g., cellulitis, erysipelas):

    • Cephalexin 500mg 3-4 times daily for 5-6 days
    • Clindamycin 300-450mg three times daily for 5-6 days (if penicillin allergic)
    • Amoxicillin-clavulanate 875/125mg twice daily for 5-6 days 2

Severe Skin Infections

  • Necrotizing fasciitis requires aggressive treatment:

    • Clindamycin plus piperacillin-tazobactam (with or without vancomycin)
    • Alternative: ceftriaxone plus metronidazole (with or without vancomycin) 1
  • For severe purulent infections:

    • Vancomycin IV
    • Linezolid
    • Daptomycin
    • Ceftaroline 1

Pathogen-Specific Treatment

Staphylococcus aureus

  • MSSA (Methicillin-Susceptible S. aureus):

    • First-line: Dicloxacillin or cephalexin 1
    • Alternative: Clindamycin or TMP-SMX 3
  • MRSA (Methicillin-Resistant S. aureus):

    • Mild infections: TMP-SMX, doxycycline, or clindamycin 1
    • Severe infections: Vancomycin IV (first-line), linezolid, or daptomycin 3, 4

Streptococcal Infections

  • Group A Streptococcus:
    • First-line: Penicillin (for isolated streptococcal infections)
    • Alternative: Cephalexin or clindamycin 1
    • For impetigo/ecthyma: 7-day regimen with anti-staphylococcal agent 1

Special Considerations

Diabetic Wound Infections

  • Mild infections: Dicloxacillin, clindamycin, cefalexin, levofloxacin, amoxicillin-clavulanic acid, or doxycycline
  • Moderate to severe infections: Levofloxacin, cefoxitin, ceftriaxone, ampicillin-sulbactam, or ertapenem
  • For suspected MRSA: Add TMP-SMX, linezolid, daptomycin, or vancomycin 1

Periorbital Cellulitis

  • Mild cases: Oral antibiotics (outpatient)
  • Moderate to severe: IV antibiotics (hospitalization)
    • First-line: Vancomycin 15-20 mg/kg IV every 8-12 hours
    • Alternatives: Daptomycin, linezolid, or clindamycin 2

Pediatric Dosing

For cefalexin in pediatric patients:

  • Usual recommended daily dosage: 25-50 mg/kg in divided doses
  • For skin infections: Total daily dose may be divided and administered every 12 hours 5

Treatment Duration

  • Standard duration for most skin infections: 5-6 days 2
  • For streptococcal pharyngitis/tonsillitis: 10 days to prevent rheumatic fever 1
  • Monitor for improvement within 72 hours; if no improvement, reevaluate treatment plan 2

Pitfalls and Caveats

  1. Increasing antibiotic resistance: Always consider local resistance patterns when selecting empiric therapy
  2. Drainage is crucial: For abscesses, surgical drainage is the primary intervention; antibiotics alone are often insufficient
  3. MRSA consideration: In areas with high MRSA prevalence, empiric coverage should include MRSA-active agents
  4. Deeper infection signs: Watch for systemic symptoms, bullae, skin sloughing, or hypotension that suggest more severe infection requiring aggressive treatment
  5. Supportive care: Don't forget elevation of affected limbs, warm compresses, and adequate pain control 2

Remember to reassess therapy after culture results become available and adjust antibiotics accordingly to prevent development of resistance.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Periorbital Cellulitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.